News
2/20/2024
Reprieve Cardiovascular Emerges from Stealth Mode after $42 Million Series A Financing to Bring Intelligent Fluid Management to Heart Failure Patients
12/13/2019
Clinical Data from Reprieve Cardiovascular's Successful First-in-Human Therapy for Acute Heart Failure Presented
5/25/2019
Reprieve Cardiovascular Announces Late-Breaking Acute Heart Failure Clinical Trial Data